NCT05024435 is a NA clinical trial of Surfactant Administration in Neonatology, sponsored by Salzburger Landeskliniken.

Who is sponsoring NCT05024435?

NCT05024435 is sponsored by Salzburger Landeskliniken.

What drugs are being tested in NCT05024435?

Interventions in NCT05024435: Surfactant Administration.

What condition does NCT05024435 study?

NCT05024435 studies Neonatology, Perinatal Distress Syndrome.

Is NCT05024435 still recruiting?

NCT05024435 is currently completed. Last updated 2 September 2021.

Last reviewed 2021-09-02 · How we verify

NCT05024435

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Semi-rigid and Flexible Catheters for Less Invasive Surfactant Administration in Preterm Infants

Completed NA Last updated 2 September 2021

What this trial tests

NA trial testing Surfactant Administration in Neonatology in 31 participants. Completed in 30 April 2020.

Timeline

1 November 2019

Primary endpoint
30 April 2020

30 April 2020

Quick facts

Lead sponsor	Salzburger Landeskliniken
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	31
Start date	1 November 2019
Primary completion	30 April 2020
Estimated completion	30 April 2020
Sites	1 location across Austria

Drugs / interventions tested

Surfactant Administration — full drug profile →

Conditions studied

Neonatology — all drugs for Neonatology →
Perinatal Distress Syndrome — all drugs for Perinatal Distress Syndrome →

Sponsor

Salzburger Landeskliniken — full company profile →

Who can join

Eligibility, any sex, with Neonatology or Perinatal Distress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of this study is to determine the differences between two surfactant administration catheters in preterm infants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome-a randomized controlled trial.
Auer-Hackenberg L, Brandner J, Hofstätter E, Stroicz P, et al · · 2022 · cited 3× · PMID 36333741 · DOI 10.1186/s12887-022-03714-3

Verify or expand the search:

Other Salzburger Landeskliniken trials

Trials by the same sponsor.

NCT06754137 — Assessing AI-Supported Fracture Detection in Emergency Care Units · NA · recruiting
NCT06402487 — Propionic Acid in Multiple Sclerosis · Phase 2, PHASE3 · completed
NCT06579911 — Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer · NA · recruiting
NCT03900364 — a Prospective Trial Comparing Robot-assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy · NA · completed
NCT03503721 — Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05024435 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Salzburger Landeskliniken
Last refreshed: 2 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05024435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing